Lexaria Bioscience Corp. (OTCMKTS:LXRP – Get Free Report) fell 10.7% during mid-day trading on Monday . The company traded as low as $0.21 and last traded at $0.22. 2,151,500 shares changed hands during trading, an increase of 254% from the average session volume of 608,350 shares. The stock had previously closed at $0.25.
Lexaria Bioscience Stock Performance
The company has a current ratio of 8.52, a quick ratio of 8.01 and a debt-to-equity ratio of 0.01. The stock’s fifty day moving average is $0.22.
Lexaria Bioscience Company Profile
Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries.
Featured Articles
- Five stocks we like better than Lexaria Bioscience
- The Basics of Support and Resistance
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Election Stocks: How Elections Affect the Stock Market
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- How to Calculate Return on Investment (ROI)
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Lexaria Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lexaria Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
